Bupivacaine liposomal injection for acute pain after hemorrhoidectomy
- Conditions
- Haemorrhoidectomy
- Registration Number
- ChiCTR2400088883
- Lead Sponsor
- Nanjing Traditional Chinese Medicine Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Prospective cohort:<br>1. Voluntarily sign informed consent;<br>2. Patients with mixed hemorrhoids undergoing elective hemorrhoidectomy;<br>3. Age =18 years old;<br>4. American Society of Anesthesiologists (ASA) grade ?~?.<br>Retrospective cohort:<br>1. Patients with mixed hemorrhoids undergoing hemorrhoidectomy;<br>2. Use of bupivacaine liposome injection or other analgesic regimens for postoperative acute pain;<br>3. Age =18 years old, regardless of gender.
Prospective cohort:<br>1. Patients with comorbid mental disorders and cognitive impairment;<br>2. Patients with sensory disorders such as hyperalgesia, or other bodily pain affecting postoperative pain assessment;<br>3. The history of myocardial infarction, unstable angina pectoris, or severe arrhythmia (such as atrioventricular block of degree ? or above) within 6 months;<br>4. Patients with diabetic peripheral neuropathy;<br>5. Abnormal liver function: aspartate aminotransferase (AST) or/and alanine aminotransferase (ALT) and/or total bilirubin (TBIL) =1.5×ULN;<br>6. Known to be allergic to bupivacaine or other amide local anesthetics;<br>7. Pregnant and lactating women;<br>8. Patients with any other factor considered by the investigator to be ineligible for the trial.<br>Retrospective cohort:<br>1. Patients with concurrent pain in other parts of the body other than the surgical site, or patients with chronic pain;<br>2. Patients with missing data information related to key studies.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The proportion of patients with NRS score =3 at rest within 72 hours after the end of surgery;
- Secondary Outcome Measures
Name Time Method NRS scores in resting/active state within 72 hours after surgery were recorded;Maximum pain intensity score during each defecation change within 3 days after surgery;Maximum pain intensity score during each dressing change within 3 days after surgery;Opioid consumption (as intravenous morphine equivalent) within 72 hours after the end of surgery;Time to first receipt of rescue analgesic within 72 hours after the end of surgery;Number of rescue analgesic administered within 72 hours after the end of surgery;The Quality of Recovery scale (QoR-15) was used to evaluate the quality of recovery at 24h and 72h after operation;Length of Stay;Opioid consumption (as intravenous morphine equivalent) within 72 hours after the end of surgery;